Skip to content

H2020FP7HORIZON

Societe Europeenne de Cardiologie

Country
FRFrance
Defence projects
0
Projects, all programmes
17
As coordinator
2
EU contribution (CORDIS)
EUR 4,634,035
Active
2009 to 2025

Projects

17 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ERISEuropean Research Institute on SimulationHORIZON2025ParticipantEUR 74,375
NextGenNEXT GENERATION TOOLS FOR GENOME-CENTRIC MULTIMODAL DATA INTEGRATION IN PERSONALISED CARDIOVASCULAR MEDICINEHORIZON2024ParticipantEUR 255,088
AI4HFTrustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart FailureHORIZON2023ParticipantEUR 427,443
CORE-MDCoordinating Research and Evidence for Medical DevicesH20202021CoordinatorEUR 448,140
RESILIENCERemote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines.H20202021ParticipantEUR 365,000
AFFECT-EUDIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITYH20202020ParticipantEUR 459,945
PROFIDImplementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarctionH20202020ParticipantEUR 248,125
TO_AITIONA high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbiditiesH20202020ParticipantEUR 204,925
TRAIN-HEARTTRAIN-HEARTH20202019PartnerEUR 0
euCanSHareAn EU-Canada joint infrastructure for next-generation multi-Study Heart researchH20202018ParticipantEUR 238,844
ESCAPE-NETEuropean Sudden Cardiac Arrest network: towards Prevention, Education and NEw TreatmentH20202017ParticipantEUR 268,171
BigData HeartBig Data 4 Better Hearts - Sofia ref.: 116074H20202017ParticipantEUR 617,035
CATCH MECharacterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the ElderlyH20202015ParticipantEUR 397,038
BETA3_LVHA multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart diseaseH20202015ParticipantEUR 142,225
MEDTECHTAMethods for Health Technology Assessment of Medical Devices: a European PerspectiveFP72013ParticipantEUR 64,050
CARDIOSCAPEA survey of the European cardiovascular research landscape and recommendations for future research strategyFP72012CoordinatorEUR 395,452
EVINCI-STUDYEvaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart DiseaseFP72009ParticipantEUR 28,180

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.